Alpa Laboratories Reports Strong Sales Growth Amid Profitability Challenges in March 2025 Results
Alpa Laboratories has reported its financial results for the quarter ending March 2025, showing net sales of Rs 39.92 crore, a notable increase from previous quarters. However, the company experienced a decline in profitability, with a profit after tax of Rs -2.12 crore and reduced operational efficiency metrics.
Alpa Laboratories, a microcap player in the Pharmaceuticals & Biotechnology industry, has recently reported its financial results for the quarter ending March 2025. The evaluation changes reflect a notable shift in the company's score, which has seen a revision from 8 to -3 over the past three months.The financial data indicates that Alpa Laboratories achieved net sales of Rs 39.92 crore, marking a significant growth of 66.1% compared to the average net sales of Rs 24.04 crore from the previous four quarters. This figure represents the highest quarterly sales recorded in the last five quarters, suggesting a positive near-term sales trend.
Conversely, the company faced challenges in profitability metrics. The profit after tax (PAT) registered at Rs -2.12 crore, reflecting a substantial decline compared to the average PAT of Rs 6.31 crore from prior quarters. Additionally, the operating profit and profit before tax figures reached their lowest points in the last five quarters, indicating a negative trend in operational efficiency. The earnings per share also fell to Rs -1.01, highlighting a decline in profitability for shareholders.
Overall, Alpa Laboratories' recent financial results showcase a mix of strong sales performance alongside significant challenges in profitability metrics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
